Biomarkers of Oxidative Stress in Heart Failure

Barry H. Trachtenberg, Joshua Hare

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Oxidative stress is the relative excess of reactive oxygen species (ROS) versus endogenous defense mechanisms. Abundant evidence has demonstrated the role of ROS, along with reactive nitrogen species (RNS), in the pathophysiology of cardiovascular disease, including heart failure. Many biomarkers of oxidative stress have been studied as surrogates of oxidative damage. Recently, markers of impaired nitric oxide signaling have also been identified. Many biomarkers have been associated with prognosis and mortality, and some may even be modified by therapy. However, the clinical utility is limited by less than optimal standardization techniques and the lack of sufficient large-sized, multimarker prospective trials.

Original languageEnglish
Pages (from-to)561-577
Number of pages17
JournalHeart Failure Clinics
Volume5
Issue number4
DOIs
StatePublished - Oct 1 2009

Fingerprint

Reactive Oxygen Species
Oxidative Stress
Heart Failure
Biomarkers
Reactive Nitrogen Species
Nitric Oxide
Cardiovascular Diseases
Mortality
Therapeutics

Keywords

  • Biomarkers
  • Heart failure
  • Isoprostane
  • Malonaldehyde
  • Myeloperoxidase
  • Oxidative stress
  • Oxidized LDL
  • Uric acid

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Biomarkers of Oxidative Stress in Heart Failure. / Trachtenberg, Barry H.; Hare, Joshua.

In: Heart Failure Clinics, Vol. 5, No. 4, 01.10.2009, p. 561-577.

Research output: Contribution to journalArticle

Trachtenberg, Barry H. ; Hare, Joshua. / Biomarkers of Oxidative Stress in Heart Failure. In: Heart Failure Clinics. 2009 ; Vol. 5, No. 4. pp. 561-577.
@article{ef260b0ead5c4732b67ad1ce236dc3ec,
title = "Biomarkers of Oxidative Stress in Heart Failure",
abstract = "Oxidative stress is the relative excess of reactive oxygen species (ROS) versus endogenous defense mechanisms. Abundant evidence has demonstrated the role of ROS, along with reactive nitrogen species (RNS), in the pathophysiology of cardiovascular disease, including heart failure. Many biomarkers of oxidative stress have been studied as surrogates of oxidative damage. Recently, markers of impaired nitric oxide signaling have also been identified. Many biomarkers have been associated with prognosis and mortality, and some may even be modified by therapy. However, the clinical utility is limited by less than optimal standardization techniques and the lack of sufficient large-sized, multimarker prospective trials.",
keywords = "Biomarkers, Heart failure, Isoprostane, Malonaldehyde, Myeloperoxidase, Oxidative stress, Oxidized LDL, Uric acid",
author = "Trachtenberg, {Barry H.} and Joshua Hare",
year = "2009",
month = "10",
day = "1",
doi = "10.1016/j.hfc.2009.04.003",
language = "English",
volume = "5",
pages = "561--577",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Biomarkers of Oxidative Stress in Heart Failure

AU - Trachtenberg, Barry H.

AU - Hare, Joshua

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Oxidative stress is the relative excess of reactive oxygen species (ROS) versus endogenous defense mechanisms. Abundant evidence has demonstrated the role of ROS, along with reactive nitrogen species (RNS), in the pathophysiology of cardiovascular disease, including heart failure. Many biomarkers of oxidative stress have been studied as surrogates of oxidative damage. Recently, markers of impaired nitric oxide signaling have also been identified. Many biomarkers have been associated with prognosis and mortality, and some may even be modified by therapy. However, the clinical utility is limited by less than optimal standardization techniques and the lack of sufficient large-sized, multimarker prospective trials.

AB - Oxidative stress is the relative excess of reactive oxygen species (ROS) versus endogenous defense mechanisms. Abundant evidence has demonstrated the role of ROS, along with reactive nitrogen species (RNS), in the pathophysiology of cardiovascular disease, including heart failure. Many biomarkers of oxidative stress have been studied as surrogates of oxidative damage. Recently, markers of impaired nitric oxide signaling have also been identified. Many biomarkers have been associated with prognosis and mortality, and some may even be modified by therapy. However, the clinical utility is limited by less than optimal standardization techniques and the lack of sufficient large-sized, multimarker prospective trials.

KW - Biomarkers

KW - Heart failure

KW - Isoprostane

KW - Malonaldehyde

KW - Myeloperoxidase

KW - Oxidative stress

KW - Oxidized LDL

KW - Uric acid

UR - http://www.scopus.com/inward/record.url?scp=67650601390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650601390&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2009.04.003

DO - 10.1016/j.hfc.2009.04.003

M3 - Article

C2 - 19631180

AN - SCOPUS:67650601390

VL - 5

SP - 561

EP - 577

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 4

ER -